CRC Credit Research Compendium
Menu
日本語English

Issuer Credit Research

Hanwha Life Insurance Issuer Flash: Q1 2026 Results

Hanwha Life Insurance Issuer Flash: Q1 2026 Results

Report date: 2026-05-14 Event date: 2026-05-12 Event title: Q1 2026 Results

Flash Conclusion

Hanwha Life Insurance (“Hanwha Life”)’s Q1 2026 results reinforced the view set out in the latest issuer_summary: issuer credit remains strong as a major Korean life insurer, but K-ICS, CSM quality, insurance earnings, investment earnings, and the terms of capital securities need to be assessed separately. According to the company-provided release, consolidated net income for Q1 2026 was KRW 381.6 billion, up 29% year on year, while separate net income was KRW 247.8 billion, up 103% year on year. The provisional DART disclosure dated 2026-05-12 also confirms consolidated revenue of KRW 9.9852 trillion, operating profit of KRW 480.8 billion, and net income of KRW 324.4 billion, and separate revenue of KRW 5.3127 trillion, operating profit of KRW 280.0 billion, and net income of KRW 247.8 billion.

The results are credit positive, but not enough to move the issuer credit view up by a notch. They should be read as one additional quarter of evidence supporting the existing view of “stable, with confirmation of gradual improvement still pending.” The estimated K-ICS ratio was 162%, improving by 4.5 percentage points from 157% at FY2025-end, but this does not mean that the capital buffer has shifted to a very thick level. New business CSM and in-force CSM increased, but CSM is not cash and remains sensitive to claims ratios, surrenders, expenses, medical utilisation, and assumption changes. For HLINSU Tier II / hybrid capital securities as well, the results provide near-term reassurance, but the conclusion that the capital securities should not be treated like senior debt remains unchanged.

What Was Announced

On 2026-05-12, Hanwha Life held its Q1 2026 results conference call and released provisional results through same-day DART disclosures and a company-provided release. The company’s main message was that both consolidated and separate net income increased, driven by growth in protection-oriented new business, improved investment earnings, and earnings contributions from the GA subsidiary, domestic financial subsidiaries, and major overseas subsidiaries.

Metric Q1 2026 result or company estimate Credit read-through
Consolidated net income KRW 381.6 billion, up 29% year on year. Company-provided release Positive indication of earnings recovery after the decline in FY2025 standalone profit
DART provisional consolidated figures Revenue of KRW 9.9852 trillion, operating profit of KRW 480.8 billion, net income of KRW 324.4 billion Earnings level improved. However, the difference from the KRW 381.6 billion figure in the release requires confirmation
Separate net income KRW 247.8 billion, up 103% year on year. Company-provided release and DART separate disclosure Important as a recovery at the operating life insurer on a standalone basis
CSM / sales Protection APE of KRW 700.3 billion, new business CSM of KRW 610.9 billion, in-force CSM of KRW 8.9209 trillion Product mix and stock of future earnings improved
Persistency ratio 13th-month persistency ratio of 90.2%, up 1.1 percentage points from year-end Positive for sales quality and policy continuation
Estimated K-ICS ratio 162%, up 4.5 percentage points quarter on quarter Confirms improvement, but still difficult to call a thick capital buffer
Subsidiary earnings GA about KRW 23.3 billion, domestic financial subsidiaries KRW 145.7 billion, major overseas subsidiaries KRW 45.3 billion Contributes to diversification of consolidated earnings

Credit Read-Through

The change in this quarter is that Q1 2026 provided an initial positive answer to the question that remained at FY2025-end: whether the decline in standalone profit would continue. The 103% year-on-year increase in separate net income indicates a recovery in earnings at the life insurance business itself, while the 25.1% increase in new business CSM and 9.8x CSM profitability suggest that product mix and profitability may have mattered more than sales volume alone.

What has not changed is that the key constraints on issuer credit remain capital and the quality of future earnings. The estimated K-ICS ratio of 162% is an improvement, but given the rating level, market access as an issuer of capital securities, expansion in protection-type insurance, and overseas and non-insurance subsidiary expansion, it is still difficult to say that the capital cushion has widened significantly. It has not been confirmed whether the improvement in K-ICS came from internal capital generation, interest-rate or valuation factors, transitional measures, changes in required capital, recognition of capital securities, or a reduction in risk volume. Capital assessment should therefore stop at “improvement confirmed, but awaiting a breakdown of quality.”

CSM growth is supportive for a life insurer under IFRS 17, but it can be eroded by actual claims and benefits, surrenders, expenses, medical utilisation, sales quality, and assumption changes. Improved investment earnings are also positive in the near term, but any portion dependent on market conditions or valuation factors has lower persistence. Subsidiary earnings support consolidated results, but P&C insurance, securities, savings bank, and overseas financial subsidiaries have credit costs and regulatory capital needs that differ from life insurance. For HLINSU capital securities, even after these results, distribution suspension, optional redemption, regulatory approval, refinancing conditions, and downside risk to K-ICS need to be assessed separately.

What To Watch Next

Next, the Q1 2026 quarterly report or IR materials should be used first to confirm the K-ICS breakdown. The headline 162% figure alone does not show reliance on transitional measures, eligible capital, required capital, or changes by interest-rate, credit, and insurance risk. Second, CSM quality should be reviewed by product and by driver. Third, investment earnings and ALM, the sustainability of subsidiary earnings, and distribution, call, and refinancing assumptions for HLINSU capital securities should be checked. The probability of call after the first reset in 2030 and market valuation should not be concluded based solely on these results.

Sources

Unverified / Pending